|
| Home : Advanced Proteome Therapeutics Corporation Announces Rights Offering |
|
Jun 02
2017 |
Advanced Proteome Therapeutics Corporation Announces Rights Offering |
|
VANCOUVER, BRITISH COLUMBIA--(Marketwired - June 1, 2017) - Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE:APC)(FRANKFURT:0E8) is pleased to announce that it will conduct a rights offering to raise gross proceeds of up to $1,900,281 (the "Rights Offering").
Under the Rights Offering, the Company will be offering transferable rights (the "Rights") to holders of its common shares (the "Common Shares") resident in Canada at the close of business on June 7, 2017 (the "Record Date"), on the basis of one Right for each Common Share held. Four Rights will entitle the holder to subscribe for one unit of the Company (a "Unit") at a subscription price of $0.06 per Unit, which represents a discount to the closing price of the Common Shares on the TSX Venture Exchange (the "Exchange") on May 31, 2017. No fractional Units will be issued. Each Unit will consist of one Common Share and one-half of one common share purchase warrant, with each whole warrant exercisable into one Common Share for a period of 12 months following the closing of the Rights Offering (the "Closing Date") at a price of $0.10 per Common Share. The Rights will expire at 5:00 p.m. (Toronto time) on July 5, 2017 (the "Expiry Time"), after which time unexercised Rights will be void and of no value. Shareholders who fully exercise their Rights will be entitled to subscribe for additional Units, if available as a result of unexercised Rights prior to the Expiry Time, subject to certain limitations set out in the rights offering circular in respect of the Rights Offering (the "Circular"). |
|
|
|
| Source:http://www.marketwired.com/mw/release.do?id=2219661&sourceType=3 |
| |
|
Related News
|
» Plato Gold Announces Private Placement of Convertible Debenture for up to $300,000
» Senators asked FBI to investigate Sessions for perjury
|
|
|
